Testing effectiveness (Phase 2)WithdrawnNCT06090318
What this trial is testing
Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss
Who this might be right for
Advanced Solid TumorCDKN2ANSCLC+7 more
Rain Oncology Inc